Skip to content
The Nexus
DossierENTITY

Kjetil Bjornevik

Coverage of Kjetil Bjornevik in the Nexus archive.

Earliest in view: Jul 15 · 18:00 UTCMost recent: Jul 15 · 18:00 UTC
Co-mentioned in this coverage
Michael Levyperson1Harvard Medical Schoolorganization1Harvard T.H. Chan School of Public Healthorganization1Natalia Drosuperson1Massachusetts General Hospitalorganization1Epstein-Barr virustopic1multiple sclerosistopic1
Recent coverage
  • HEALTHJul 15 · 18:00 UTCNEW SCIENTIST
    Best treatment for multiple sclerosis may be antivirals

    Research suggests antivirals targeting the Epstein-Barr virus (EBV) may be the most effective treatment for multiple sclerosis (MS). Studies found people with MS produce twice as many CD4 T-cells targeting proteins from actively replicating EBV compared to those without MS, indicating a distinct immune response. Researchers urge pharmaceutical companies to develop EBV-specific antiviral drugs for future MS therapy.

Kjetil Bjornevik · Dossier · The Nexus